MBC - Metastatic Breast Cancer NewsLatest News On MBC - Metastatic Breast Cancer Doing the Best They Can11/14/2024 2:20 PM Starting Mammograms at Age 40: Will Women Benefit?10/29/2024 9:36 AM FDA Approves Inavolisib for HR+, HER2−, Advanced Breast Cancer With PIK3CA Mutation10/11/2024 2:44 AM By the Numbers: Monthly Treatment Cost Not Tied to Survival in Breast Cancer9/26/2024 7:31 AM Mental Health Considerations in Metastatic Breast Cancer: 5 Things to Know9/18/2024 9:20 AM Most Oncology Patients Interested in Discussing Flexible Dosing9/18/2024 9:18 AM Trastuzumab Deruxtecan Shows Promise in HER2+ BC with Brain Metastases9/15/2024 12:42 PM Optimal Management of Side Effects Associated With PIK3CA and mTOR Inhibitors8/7/2024 10:31 AM BC Patients See Minimal Cognitive Decline with CDK4/68/1/2024 5:09 AM Black Women With Breast Cancer Face Clinical Inequities7/30/2024 3:20 AM Eribulin Effective When Paired With Dual HER2 Blockade in BC7/12/2024 2:52 AM PFS Benefits Seen With Palbociclib + Endocrine Therapy in BC7/11/2024 2:44 AM New Approaches in the Treatment of HR+ Metastatic Breast Cancer7/10/2024 8:07 AM New ADC Results Mixed in Metastatic Breast Cancer7/10/2024 3:50 AM A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?6/13/2024 4:40 AM Abemaciclib Combo Improves Survival in Advanced Breast Cancer6/6/2024 9:56 AM Exercise Improves Sexual Health in Women With Metastatic Breast Cancer5/22/2024 6:39 AM ADCs for Breast Cancer: Clear Benefits, Manageable Risks5/21/2024 1:58 AM More Is Not Always Better: Outdated Drug Dose Strategy in Breast Cancer5/9/2024 5:39 AM Europe Recommends Three Cancer Drugs4/26/2024 10:18 AM
